Literature DB >> 11956174

Transcriptional activity of nuclei in multinucleated osteoclasts and its modulation by calcitonin.

Patrice Boissy1, Frederic Saltel, Christine Bouniol, Pierre Jurdic, Irma Machuca-Gayet.   

Abstract

The function of osteoclasts is to digest the calcified bone matrix. Osteoclasts, together with myotubes, are among the rare examples of multinucleated cells found in higher vertebrates, resulting from the fusion of mononucleated progenitors belonging to the monocyte/macrophage lineage. So far, no information is available about function and transcriptional activity of multiple nuclei in osteoclasts. We have used a run-on technique to visualize RNA synthesis in individual nucleus. We provide the first evidence that nuclei of resorbing osteoclasts, isolated from chick embryo long bones, or differentiated in vitro from murine spleen cells in presence of RANKL and macrophage-colony stimulating factor, are all transcriptionally active. Nevertheless, if transcriptional activity is the same for all the nuclei within a cell, its level varies between osteoclasts: osteoclasts with highly active nuclei are always associated with resorption pits. We found that global transcription activity of resorbing osteoclasts seeded on calcified matrix is down-regulated after 5-h treatment with calcitonin, which transiently blocks resorption. This effect is reversible because calcitonin removal led to nuclear transcription activation. These results indicate a strong correlation between transcription and resorption. Finally, our data indicate that the resorption pit surface is linearly related to the nuclei number per osteoclast, strongly suggesting that functional advantage of osteoclast multinucleation is to improve resorption efficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956174     DOI: 10.1210/endo.143.5.8813

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts.

Authors:  Tao Ma; Kavitha Sadashivaiah; Nandakumar Madayiputhiya; Meenakshi A Chellaiah
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

2.  E proteins regulate osteoclast maturation and survival.

Authors:  Courtney L Long; William L Berry; Ying Zhao; Xiao-Hong Sun; Mary Beth Humphrey
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

3.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 4.  Functional Heterogeneity Within Osteoclast Populations-a Critical Review of Four Key Publications that May Change the Paradigm of Osteoclasts.

Authors:  Neha Sharma; Megan M Weivoda; Kent Søe
Journal:  Curr Osteoporos Rep       Date:  2022-07-15       Impact factor: 5.163

5.  Giant osteoclast formation and long-term oral bisphosphonate therapy.

Authors:  Robert S Weinstein; Paula K Roberson; Stavros C Manolagas
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

6.  Multinucleated giant cell phenotype in response to stimulation.

Authors:  Kevin L Trout; Andrij Holian
Journal:  Immunobiology       Date:  2020-05-05       Impact factor: 3.144

7.  Divergent effects of strontium and calcium-sensing receptor positive allosteric modulators (calcimimetics) on human osteoclast activity.

Authors:  Natalie A Diepenhorst; Katie Leach; Andrew N Keller; Patricia Rueda; Anna E Cook; Tracie L Pierce; Cameron Nowell; Philippe Pastoureau; Massimo Sabatini; Roger J Summers; William N Charman; Patrick M Sexton; Arthur Christopoulos; Christopher J Langmead
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

8.  An SNX10-dependent mechanism downregulates fusion between mature osteoclasts.

Authors:  Maayan Barnea-Zohar; Sabina E Winograd-Katz; Moran Shalev; Esther Arman; Nina Reuven; Lee Roth; Ofra Golani; Merle Stein; Fadi Thalji; Moien Kanaan; Jan Tuckermann; Benjamin Geiger; Ari Elson
Journal:  J Cell Sci       Date:  2021-05-11       Impact factor: 5.285

9.  Purinergic signalling in bone.

Authors:  Robin M H Rumney; Ning Wang; Ankita Agrawal; Alison Gartland
Journal:  Front Endocrinol (Lausanne)       Date:  2012-09-19       Impact factor: 5.555

10.  Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice.

Authors:  Bongjin Shin; Henry C Hrdlicka; Anne M Delany; Sun-Kyeong Lee
Journal:  Endocrinology       Date:  2021-10-01       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.